Franklin Parlapiano Turner & Welch LLC grew its holdings in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 0.4% during the second quarter, Holdings Channel.com reports. The firm owned 50,925 shares of the company’s stock after acquiring an additional 221 shares during the quarter. Procter & Gamble accounts for about 2.1% of Franklin Parlapiano Turner & Welch LLC’s portfolio, making the stock its 13th biggest position. Franklin Parlapiano Turner & Welch LLC’s holdings in Procter & Gamble were worth $8,113,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Means Investment CO. Inc. raised its holdings in shares of Procter & Gamble by 15.7% in the second quarter. Means Investment CO. Inc. now owns 27,484 shares of the company’s stock valued at $4,379,000 after purchasing an additional 3,739 shares during the last quarter. Vanguard Personalized Indexing Management LLC raised its holdings in shares of Procter & Gamble by 13.1% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 323,679 shares of the company’s stock valued at $51,576,000 after purchasing an additional 37,576 shares during the last quarter. Sovereign Financial Group Inc. raised its holdings in shares of Procter & Gamble by 1.1% in the second quarter. Sovereign Financial Group Inc. now owns 5,823 shares of the company’s stock valued at $928,000 after purchasing an additional 65 shares during the last quarter. Concurrent Investment Advisors LLC increased its holdings in Procter & Gamble by 4.5% during the second quarter. Concurrent Investment Advisors LLC now owns 125,408 shares of the company’s stock worth $19,980,000 after buying an additional 5,406 shares during the last quarter. Finally, Cerro Pacific Wealth Advisors LLC increased its holdings in Procter & Gamble by 4.0% during the second quarter. Cerro Pacific Wealth Advisors LLC now owns 12,538 shares of the company’s stock worth $1,998,000 after buying an additional 477 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
PG has been the topic of a number of recent analyst reports. Evercore ISI restated an “in-line” rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Berenberg Bank boosted their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a report on Wednesday, September 17th. Barclays lowered their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. Bank of America lowered their target price on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, BNP Paribas Exane lowered their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a report on Tuesday, September 23rd. Eleven analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average price target of $172.21.
Insider Transactions at Procter & Gamble
In other news, CFO Andre Schulten sold 11,638 shares of the business’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,830,308.26. Following the completion of the sale, the chief financial officer owned 52,642 shares of the company’s stock, valued at approximately $8,279,007.34. The trade was a 18.11% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Jon R. Moeller sold 40,119 shares of the business’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the completion of the sale, the chief executive officer directly owned 319,375 shares of the company’s stock, valued at approximately $50,228,106.25. The trade was a 11.16% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 149,763 shares of company stock valued at $23,421,279. Corporate insiders own 0.20% of the company’s stock.
Procter & Gamble Price Performance
NYSE:PG opened at $149.69 on Friday. Procter & Gamble Company has a one year low of $149.45 and a one year high of $180.43. The company has a market cap of $350.34 billion, a P/E ratio of 22.99, a P/E/G ratio of 3.97 and a beta of 0.36. The firm’s fifty day moving average price is $155.24 and its two-hundred day moving average price is $159.48. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same period in the previous year, the company earned $1.40 earnings per share. The company’s quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
- Five stocks we like better than Procter & Gamble
- How to Use Stock Screeners to Find Stocks
- Bassett Furniture: Buy Now, Sit Back, and Collect Dividends
- Low PE Growth Stocks: Unlocking Investment Opportunities
- AST SpaceMobile’s Big Win: Shares Soar on New Deal With Verizon
- How to Invest in Blue Chip Stocks
- Catch the Next Bitcoin Rally With These 3 ETFs
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.